Ritlecitinib rescues exacerbated vitiligo during the JAK1 inhibitor therapy: More than a coincidence?
Indian Journal of Dermatology, Venereology and Leprology · 04.10.2024 · 92 · 729-731
DOI: 10.25259/ijdvl_348_2024 ↗Kurz gefasst
Leserbrief in der Zeitschrift Indian Journal of Dermatology, Venereology and Leprology, online erschienen am 04.10.2024. Verfasst von Zequn Tong und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Dermatology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
- Department of Central Laboratory, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, China.
Zitieren
APA
Tong, Z., Wu, Z., Zeng, X., Huang, F., Gong, T., & Ji, C. (2024). Ritlecitinib rescues exacerbated vitiligo during the JAK1 inhibitor therapy: More than a coincidence?. Indian Journal of Dermatology, Venereology and Leprology, 92, 729-731. https://doi.org/10.25259/ijdvl_348_2024
Vancouver
Tong Z, Wu Z, Zeng X, Huang F, Gong T, Ji C. Ritlecitinib rescues exacerbated vitiligo during the JAK1 inhibitor therapy: More than a coincidence?. Indian Journal of Dermatology, Venereology and Leprology. 2024;92:729-731. doi:10.25259/ijdvl_348_2024
BibTeX
@article{Tong2024,
author = {Tong, Zequn and Wu, Zhenlan and Zeng, Xueting and Huang, Fuchen and Gong, Ting and Ji, Chao},
title = {Ritlecitinib rescues exacerbated vitiligo during the JAK1 inhibitor therapy: More than a coincidence?},
journal = {Indian Journal of Dermatology, Venereology and Leprology},
year = {2024},
volume = {92},
pages = {729--731},
doi = {10.25259/ijdvl_348_2024}
}
EUVIMED